HV
Hatteras Venture Partners
Venture CapitalActiveHatteras Venture Partners is a North Carolina-based venture capital firm that finances biomedical companies.
75
Investments
16
Exits
$272M
AUM
21.3%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Hatteras Venture Partners.
Investment Thesis & Strategy
Hatteras Venture Partners invests in biomedical companies across various stages, leveraging its North Carolina base to support innovation in the healthcare sector.
Investment Activity
Deals per year over the last 15 years
1
20001
20010
20020
20030
20042
20051
20062
20070
20080
20091
20101
20110
20122
20131
2014Portfolio Companies
Selected investments from their portfolio of 75 companies
G
G1 Therapeutics
Biotech · Series A, 2014
C
CoLucid Pharmaceuticals
Biotech · Series A, 2013
N
Novan
Biotech · Series A, 2013
S
Spinifex Pharmaceuticals
Biotech · Series A, 2011
H
Heat Biologics
Biotech · Series A, 2010
V
Viamet Pharmaceuticals
Biotech · Series A, 2007
C
Clinipace
Healthcare · Growth, 2007
E
Enanta Pharmaceuticals
Biotech · Series A, 2006
A
Argos Therapeutics
Biotech · Series A, 2005
A
Aerocrine
Biotech · Growth, 2005
C
Chimerix
Biotech · Series A, 2001
R
RTI Surgical
Biotech · Series A, 2000
Frequently Asked Questions
Hatteras Venture Partners focuses on Series A, Series B, Series C+ stage investments.